References
- International Diabetes FederationIDF Diabetes Atlas8th edBrusselsInternational Diabetes Federation2017 http://www.diabetesatlas.orgAccessed October 7, 2018
- KaveeshwarSACornwallJThe current state of diabetes mellitus in IndiaAustralas Med J201471454824567766
- American Diabetes AssociationStandards of medical care in Diabetes-2017: summary of revisionsDiabetes Care201740Suppl 1S4S527979887
- GarberAJAbrahamsonMJBarzilayJIConsensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm – 2017 executive summaryEndocr Pract201723220723828095040
- BonnetFScheenAUnderstanding and overcoming metformin gastrointestinal intoleranceDiabetes Obes Metab201719447348127987248
- KimCHHanKAOhHJSafety, tolerability, and efficacy of metformin extended-release oral antidiabetic therapy in patients with type 2 diabetes: an observational trial in AsiaJ Diabetes20124439540622742083
- JabbourSZiringBAdvantages of extended-release metformin in patients with type 2 diabetes mellitusPostgrad Med20111231152321293080
- LevyJCobasRAGomesMBAssessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitusDiabetol Metab Syndr2010211620298568
- TungarazaTETalapan-ManikothPJenkinsRCurse of The ghost pills: the role of oral controlled-release formulations in the passage of empty intact shells in faeces. Two case reports and a literature review relevant to psychiatryTher Adv Drug Saf201342637125083252
- DujicTZhouKDonnellyLATavendaleRPalmerCNAPearsonERAssociation of organic cation transporter 1 with intolerance to metformin in type 2 diabetes: a GoDARTS studyDiabetes20156451786179325510240
- JinJSklarGEMin Sen OhVChuen LiSFactors affecting therapeutic compliance: a review from the patient’s perspectiveTher Clin Risk Manag20084126928618728716
- BhosleMBennerJSDekovenMSheltonJDifficult to swallow: patient preferences for alternative valproate pharmaceutical formulationsPatient Prefer Adherence20093316117119936158
- ChannerKSVirjeeJPThe effect of size and shape of tablets on their esophageal transitJ Clin Pharmacol19862621411463950057
- LiuFRanmalSBatchelorHKPatient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populationsDrugs201474161871188925274536
- ECRI Health Technology Assessment GroupDiagnosis and treatment of swallowing disorders (dysphagia) in acute-care stroke patientsEvid Rep Technol Assess (Summ)1999816
- Harris Interactive IncPill-Swallowing Problems in America: A National Survey of AdultsNew York, NYHarris Interactive Inc. for Schwarz Pharma2003139
- HeyHJørgensenFSørensenKHasselbalchHWambergTOesophageal transit of six commonly used tablets and capsulesBr Med J19822856356171717196816343
- OvergaardABHøjstedJHansenRMøller-SonnergaardJChristrupLLPatients’ evaluation of shape, size and colour of solid dosage formsPharm World Sci200123518518811721676
- MukherjeeSSharmasarkarBDasKKBhattacharyyaADebACompliance to anti-diabetic drugs: observations from the diabetic clinic of a medical college in Kolkata, IndiaJ Clin Diagn Res20137466166523730641
- PascalIOfoeduJUchennaNNkwaAUchammaGUBlood glucose control and medication adherence among adult type 2 diabetic Nigerians attending a primary care clinic in under-resourced environment of Eastern NigeriaN Am J Med Sci20124731031522866268
- DavidsonJHowlettHNew prolonged-release metformin improves gastrointestinal tolerabilityBr J Diabetes Vasc Dis200444273277
- DerosaGD’AngeloARomanoDMaffioliPEffects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetesDrug Des Devel Ther20171114811488
- KandiMSivasaiGRathnanandMReddyMSBhaskerKVNovel intervention to improve adherence to medication in diabetic patients: formulation and evaluation of metformin HCL novel dosage formInt J Pharm Sci20135587592